Depression induces structural and functional synaptic plasticity in brain reward circuits, although the mechanisms promoting these changes and their relevance to behavioral outcomes are unknown. Transcriptional profiling of the nucleus accumbens (NAc) for Rho GTPase-related genes, which are known regulators of synaptic structure, revealed a sustained reduction in RAS-related C3 botulinum toxin substrate 1 (Rac1) expression after chronic social defeat stress. This was associated with a repressive chromatin state surrounding the proximal promoter of Rac1. Inhibition of class 1 histone deacetylases (HDACs) with MS-275 rescued both the decrease in Rac1 transcription after social defeat stress and depression-related behavior, such as social avoidance. We found a similar repressive chromatin state surrounding the RAC1 promoter in the NAc of subjects with depression, which corresponded with reduced RAC1 transcription. Viral-mediated reduction of Rac1 expression or inhibition of Rac1 activity in the NAc increases social defeat-induced social avoidance and anhedonia in mice. Chronic social defeat stress induces the formation of stubby excitatory spines through a Rac1-dependent mechanism involving the redistribution of synaptic cofilin, an actin-severing protein downstream of Rac1. Overexpression of constitutively active Rac1 in the NAc of mice after chronic social defeat stress reverses depression-related behaviors and prunes stubby spines. Taken together, our data identify epigenetic regulation of RAC1 in the NAc as a disease mechanism in depression and reveal a functional role for Rac1 in rodents in regulating stress-related behaviors.
Depression induces structural and functional synaptic plasticity in brain reward circuits, although the mechanisms promoting these changes and their relevance to behavioral outcomes are unknown. Transcriptional profiling of the nucleus accumbens (NAc) for Rho GTPase-related genes, which are known regulators of synaptic structure, revealed a sustained reduction in RAS-related C3 botulinum toxin substrate 1 (Rac1) expression after chronic social defeat stress. This was associated with a repressive chromatin state surrounding the proximal promoter of Rac1. Inhibition of class 1 histone deacetylases (HDACs) with MS-275 rescued both the decrease in Rac1 transcription after social defeat stress and depression-related behavior, such as social avoidance. We found a similar repressive chromatin state surrounding the RAC1 promoter in the NAc of subjects with depression, which corresponded with reduced RAC1 transcription. Viral-mediated reduction of Rac1 expression or inhibition of Rac1 activity in the NAc increases social defeat-induced social avoidance and anhedonia in mice. Chronic social defeat stress induces the formation of stubby excitatory spines through a Rac1-dependent mechanism involving the redistribution of synaptic cofilin, an actin-severing protein downstream of Rac1. Overexpression of constitutively active Rac1 in the NAc of mice after chronic social defeat stress reverses depression-related behaviors and prunes stubby spines. Taken together, our data identify epigenetic regulation of RAC1 in the NAc as a disease mechanism in depression and reveal a functional role for Rac1 in rodents in regulating stress-related behaviors.
The treatment of major depressive disorder (MDD) is confounded by high rates of treatment resistance, coupled with a low probability of achieving lasting remission[1]. Classically prescribed monoaminergic modulators regularly lead to measurable improvement in only half of the depressed clinical population, and remission in less than 30–40%[2]. Such clinical realities, paired with an estimated depression-related economic burden in excess of US$80 billion dollars annually[3,4], has led to a concerted effort to identify and develop novel alternative therapeutic approaches based on validated disease mechanisms to treat depression and related mood disorders.Although the monoamine hypothesis of depression[5] has dominated depression treatment strategies, recent work suggests that the neuropathology of depression is stratified across a number of biological domains such as inflammatory cytokines[6], neurotrophic factors[7], and glutamate[8]. One commonality observed between these divergent systems is that they all robustly regulate excitatory synaptic structure[9-11] and have been shown functionally to play an important role in the etiology of depression and anxiety-like behavior[7,12]. It has been suggested that classical antidepressant drugs may produce their effects through rewiring of excitatory synapses in mood circuitry[13]. Interestingly, the NMDA antagonist ketamine rapidly and transiently produces antidepressant effects in concert with alterations in synaptogenesis[14,15].While it is clear that synaptic loss occurs in cortical regions in depression[16], a major question has been whether depression or anxiety is caused by an underlying synaptic pathology in reward circuits. Evidence in rodent models show that chronic stress regulates synaptic and structural plasticity most profoundly in reward-related limbic regions[17]. Recent work from our laboratory showed that chronic social defeat stress induces structural and functional synaptic plasticity on medium spiny neurons (MSNs) in the nucleus accumbens (NAc)[17], a brain region well known for controlling reward dysfunction in depression[18]. Although the phenomena of stress-induced structural plasticity have been observed across multiple species and stress models, the intracellular mechanisms underlying these neuronal alterations and their relevance to humandepression are poorly understood.Under non-pathological conditions, small RhoGTPases, such as RAS-related C3 botulinum substrate 1 (Rac1), act as critical modulators of synaptic structure. Here we report that Rac1 is transcriptionally downregulated in NAc through an epigenetic mechanism in major depressive disorder subjects, an effect that is recapitulated in the chronic social defeat stress model of depression-like behaviors. Functionally, Rac1 modulates depression-related behaviors such as social avoidance and anhedonia, as well as MSN structural plasticity. Either a viral gene therapy based, or epigenetic rescue of, Rac1 downregulation has strong anti-stress efficacy.
RESULTS
Stress-induced transcriptional regulation of Rac1 in pre-clinical models of depression
Pathway analysis of gene ontology groups from micro-array data commonly identify cytoskeleton-related and small RhoGTPase signaling pathways as highly modulated by stress and depression-like behavioral paradigms, both in the NAc[19,20] and other limbic regions[21,22]. This is not unexpected due to the well understood phenomenological role of structural plasticity in stress and depression. Small GTPases are responsible, to a large extent, for regulation and reorganization of the actin cytoskeleton in a number of biological systems, including neuronal populations during synaptogenesis and dendritic spine maintenance[23]. They are modulated by upstream factors such as guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs), leading ultimately to the severing of the underlying actin cytoskeleton via cofilin[23,24].Although a number of pre-clinical animal models of depression have been developed, prolonged social stress has proven especially useful in revealing the molecular and cellular mechanisms underlying mood- or anxiety-related disorders[25]. In this model, male C57BL/6J mice are repeatedly subjected to bouts of social defeat by a larger and more aggressive CD-1 mouse, resulting in a majority of animals (termed susceptible) developing a syndrome highlighted by enduring social avoidance and anhedonia to previously pleasurable activities. Non-susceptible animals (termed resilient), which fail to show social avoidance and anhedonic response, generally constitute one-third of mice subjected to social defeat[26]. Therefore, the behavioral syndrome induced by social defeat allows for detailed dissection of individual variations in the molecular mechanisms that underlie stress-related behavioral phenotypes. It is important to note that social defeat stress results in the development of anxiety-like behaviors in both the susceptible and resilient populations, reinforcing the likelihood that this model captures components of depression, post-traumatic stress disorder or even social anxiety[19].Based on the lines of evidence outlined above, we utilized a transcriptional profiling procedure to identify transcriptional regulation of RhoGTPase-related genes in the NAc of susceptible and resilient mice following social defeat. Although we paneled 13 RhoGTPase-related genes, only Rac1 showed selective stress-induced transcriptional regulation in susceptible, but not resilient, mice (Fig. 1a; Supplementary Table 1). Forty-eight hr following the final defeat episode, Rac1 expression is strongly downregulated (Fig. 1b) and correlated with social avoidance behavior (Fig. 1c) (see Supplemental Fig. 1a–p for detailed behavioral data). The selective downregulation of Rac1 in the NAc of susceptible mice is not generally observed throughout other limbic structures. For example, in the prefrontal cortex (PFC) Rac1 is unaffected by social defeat stress, and in the dorsal striatum Rac1 mRNA is decreased in both susceptible and resilient mice (Supplemental Table 2). Importantly, Rac1 deletion in PFC or dorsal striatum has no effect on social avoidance behavior (Supplemental Table 2).
Figure 1
Transcriptional profiling reveals that chronic social defeat stress produces a long-lasting and selective decrease in Rac1 mRNA expression in the NAc of susceptible, but not resilient, mice. (a) mRNA expression of small RhoGTPase-related genes in the NAc of C57BL/6J mice 48 hrs following their last social defeat exposure. (b) Temporal profile of Rac1 mRNA expression in the NAc 4, 24 and 48 hrs following chronic social defeat stress. (c) Correlation of 48 hr Rac1 mRNA expression with social avoidance behavior. (d) Rac1 mRNA expression following a 35 d schedule of once daily antidepressant administration (20 mg kg−1 imipramine or vehicle, i.p). (e) Total Rac1 protein levels 48 hr after chronic social defeat stress in the NAc. (f) Correlation of total Rac1 protein with social avoidance behavior. (g) Left bars represent NAc Rac1 mRNA expression 48 hr following a single acute social defeat stress. Right bars indicate NAc Rac1 mRNA expression 48 hr following an acute injection of imipramine (20 mg kg−1, i.p.) or vehicle in previously susceptible mice. All data presented as mean ± SEM, group size is indicated in either figure legends or within graph bars; (g) *P <0.05 compared by students t-test, (a, b, e) *P <0.05 by one-way ANOVA, (d) *P <0.05 by two-way ANOVA, (c,f) P <0.05 compared by Pearson's r.
Within the NAc, Rac1 transcriptional downregulation and social avoidance behavior are both long-lasting, for at least 35 days, and partially reversible by chronic anti-depressant treatment (20 mg kg−1 imipramine i.p., once-daily for 35 d) (Fig. 1d; Supplemental Fig. 2a–b). A single acute imipramine treatment following chronic social defeat stress neither regulated Rac1 mRNA expression in the NAc (Fig. 1g), nor reversed social avoidance in susceptible mice (Supplemental Fig. 2c–d). The robust transcriptional downregulation of Rac1 by chronic social defeat stress is translated into decreased total Rac1 protein levels in susceptible, but not resilient, mice 48 hr following the final defeat session (Fig. 1e) and there is a trend for this measure to correlate with social avoidance behavior (Fig. 1f). Neither mRNA or protein levels of downstream effectors of the Rac1 signaling cascade, such as p21-activated kinase 1 (Pak1) and LIM-domain containing protein kinase (LIMK), were affected by social defeat at similar time points (Fig. 1a, Supplemental Fig. 3a–c). Notably, a single social defeat episode does not regulate Rac1 transcription (Fig. 1g), indicating that only prolonged or severe stressors that induce significant depression-like behaviors are capable of inducing downregulation of Rac1.
Stress-induced epigenetic regulation of Rac1 in a pre-clinical depression model
Genome-wide promoter analysis using chromatin immunoprecipitation paired to microarray analysis (ChIP-Chip) has recently identified increased repressive histone H3 lysine 9 (H3K9me3) and 27 (H3K27me3) methylation in the NAc of mice along the promoter region of Rac1 following social isolation stress[27]. Based on our finding that Rac1 transcription is downregulated for extended periods following chronic social defeat stress, we next explored the possibility that this transcriptional decrease is controlled through an epigenetic mechanism that selectively modifies the chromatin architecture surrounding the Rac1 promoter region. Our mouse brain-tissue ChIP assay utilizes sonication for genomic DNA fragmentation resulting in 350–750bp fragments[28]. We then designed primer pairs (Supplemental Table 3) sequentially aligned from the promoter region and extending ~2000bp upstream of the transcription start site (TSS) on Rac1 (Fig. 2a). Using site-directed quantitative chromatin immunoprecitation (qChIP) we examined permissive histone 3 acetylation (acH3) and repressive H3K27me3. It is important to note that, unlike acH3, methylation at H3K27 has been shown to be either repressive or permissive under varying biological conditions. However, recent evidence suggests that in adult mouse NAc, levels of H3K27me3 within the gene promoter region correlates with repressed gene expression (J.F., M.W., X.L., D.F., V.V, P.K, J.K, C.D, N.S., I.M., B.L., Q.L., M.C., L.S, E.J.N, SfN 2012 Abstract 458.12/T7). Across both the promoter and 2000bp upstream region, permissive acetylation is significantly reduced in the susceptible, but not resilient, populations (Fig. 2b). Conversely, methylation is differentially modulated at the proximal promoter and immediate 1000bp upstream region; within the promoter region resilient mice show reduced methylation, and directly upstream of the promoter, susceptible mice have enhanced methylation (Fig. 2c). These patterns of histone architecture surrounding the Rac1 promoter and upstream regulatory regions are strongly correlated with social avoidance behavior (Supplemental Fig. 3a–d) for both acetylation and methylation.
Figure 2
Epigenetic regulation of Rac1 following chronic social defeat stress. (a) A schematic of the mouse Rac1 gene promoter and upstream regulatory region. Purple upper-case text represents the promoter region and green lower-case text represents the untranslated region upstream of the TSS. Blue and yellow boxes represent the promoter primer pair locations sequentially aligned throughout the sequence. Profile of (b) permissive H3 acetylation and (c) repressive tri-methylation on H3K27 along the mouse Rac1 promoter and upstream gene sequence in the NAc 48 hrs following chronic social defeat stress. (d) Schematic detailing experimental protocol for intra-NAc minipump infusion of the class 1 HDAC inhibitor, MS-275. Infusion of MS-275 (100 μm) in the NAc of previously susceptible mice reverses (e) social avoidance and (f) increases Rac1 mRNA expression. (g) Correlation of social avoidance behavior and NAc Rac1 mRNA expression. All data presented as mean ± SEM, group size is indicated in either figure legend or within graph bars; (b,c) *P < 0.05, **P < 0.01, ***P < 0.001 by one-way ANOVA, (e,f) ***P < 0.001 by students t-test, (g) P <0.05 compared by Pearson's r.
Given that we found the largest and widest-spanning decreases in H3 acetylation in susceptible mice, we administered the class 1 HDAC inhibitor, MS-275, locally into the NAc for 10 days via osmotic minipump (Fig. 2d). This results in a robust reversal of social avoidance in previously susceptible mice (Fig. 2e). Importantly, Rac1 mRNA was normalized and levels were positively correlated with social interaction, suggesting that there is indeed a functional link between epigenetic regulation of Rac1 and social defeat behavior (Fig. 2e,g).
Transcriptional and epigenetic regulation of Rac1 in MDD subjects
Having identified a robust epigenetic mechanism in our chronic social defeat model, we next extended these findings to post-mortem NAc tissue derived from MDD subjects (Fig. 3a). We utilized samples from two independently collected MDD cohorts, one from UT Southwestern in Texas and the other from McGill University in Montreal. Although all subjects in both cohorts had been on antidepressant medication at some point throughout their life, roughly half in each cohort were on medication at their time of death as determined by toxicology reports (complete demographics in Supplemental Table 4 and 5). As observed in rodent models, Rac1 expression is strongly down regulated in non-medicated depressed subjects from both cohorts (Fig. 3b). Results for the depressed medicated subjects were somewhat mixed. In the Texas cohort there was no significant effects of medication status on Rac1 mRNA, however, in the larger Montreal cohort, though the trend for reduced Rac1 mRNA was still evident, there was a bimodal distribution with some subjects exhibiting Rac1 levels similar to controls. These findings are consistent with our mouse model, which shows that Rac1 decreases in susceptible mice are only normalized by chronic antidepressant treatment in about 50% (4 of 7 exhibit social interactions ratios above 1.0; see Supplemental Fig. 2a). In addition, Rac1 mRNA was not reduced in a separate human cohort of cocaine addiction cases, suggesting that this is at least partly specific to MDD (Supplementary Fig. 5). Interestingly, these data are consistent with previous work[29], showing that chronic cocaine in mice transiently decreases NAc Rac1 protein activity, with no effect on Rac1 gene transcription. Thus, we feel that this is compelling evidence to suggest that Rac1 downregulation is not an artifact of addictive drugs or antidepressant medication, nor is it a general marker of all psychiatric illnesses.
Figure 3
Epigenetic regulation of Rac1 mRNA expression in subjects with MDD. (a) Coronal and sagittal schematic of the human brain highlighting regions of NAc dissection in MDD subjects. Scale bars represent 10 mm. (b) Rac1 mRNA levels from the NAc of depressed subjects in two separate cohorts. Number of samples per cohort is shown in the table (complete demographics available in Supplemental Tables 4 and 5). (c) Schematic of the human Rac1 gene promoter region and its ~1000bp upstream sequence. Purple upper-case text represents the promoter region and green lower-case text represents the untranslated region upstream of the TSS. Blue and yellow boxes represent the promoter primer pair locations sequentially aligned throughout the sequence. (d) Profile of permissive H3 acetylation along the human Rac1 promoter and upstream sequence in the NAc. (e) Profile of repressive tri-methylation on H3K27 along the human Rac1 promoter and upstream sequence in the NAc. (f) Correlation of human NAc H3 acetylation levels with Rac1 mRNA expression. (g) Correlation of human NAc H3K27 trimethylation levels with Rac1 mRNA expression. *P < 0.05, **P < 0.01 by one-way ANOVA (b) and students t-test (d,e), P <0.05 compared by Pearson's r (f,g).
To examine chromatin structure around the Rac1 gene, we adapted our qChIP protocol for use in fresh frozen human post-mortem NAc tissue, through the use of a micrococcal nuclease (MNase) based assay[30], which reliably results in 146 to 165bp fragments (Supplemental Fig. 6a–b). We used this to create a high-resolution map of the humanRac1 promoter and 1000bp upstream regulatory region, by designing closely grouped sequentially aligned primer pairs (Supplemental Table 6) and site-directed qChIP (Fig. 3c). This sequence length was selected due to our observation that Rac1 chromatin landscape modification was most strongly regulated in mouse NAc tissue within the first 1000bp. We found decreased acetylation of Rac1 promoter sequence ~200bp up- and downstream of the TSS (Fig. 3d), while increased methylation is observed only ~200bp upstream of the transcription start site (Fig. 3e). Since qChIP was performed from the same human tissue samples as the Texas cohort cDNA library, we next directly correlated Rac1 mRNA expression with promoter acetylation (Fig. 3f) and methylation (Fig. 3g) values. As shown, acH3 enrichment ~200bp upstream of the TSS significantly correlated with Rac1 mRNA values. Importantly, re-analysis of qChIP data using medication status at time of death as a co-factor revealed no effect of medication (Supplemental Fig. 7a–b), similar to Rac1 transcription.
Rac1 modulates depression-related behavior
Based on our initial findings that Rac1 is selectively transcriptionally regulated in NAc following stress in an animal model, and in MDD subjects, we next directly examined its role in regulating depression-like behavior following social defeat stress. Using a combination of viral gene transfer and targeted genetic Rac1 knockout mice, we tested whether Rac1 in NAc is both necessary and sufficient for the expression of depression-like behaviors following either chronic social defeat or a subthreshold microdefeat (Fig. 4). Unlike chronic social defeat, microdefeats do not result in the development of any social avoidance and anhedonia in control mice, which can help to reveal pro-susceptibility factors.
Figure 4
Regulation of Rac1 by viral-mediated gene transfer and gene knockout modulates stress-related behavior in mice. (a) Representative schematic of the mouse NAc region and HSV expression. GFP-labeled neurons in green show the spread of viral infection, which is limited to the NAc region. Scale bar represents 50 μm. GFP-infected neurons strongly express GFP in the distal dendrites of MSNs. Scale bar represents 5 μm (b) Experimental schematic of chronic social defeat stress and microdefeat protocols, detailing timing for viral infection and behavioral testing. (c,d,e) Removal of Rac1 via infection of a CRE expressing HSV in the NAc of fl/fl Rac1 mice promotes susceptibility to depression-like behavior as measured by increased social avoidance and decreased sucrose preference following microdefeat. (f,g) Viral-mediated gene transfer of RacDN similarly induces social avoidance behavior following microdefeat. (h,i) Viral-mediated gene transfer of RacCA into the NAc of susceptible mice is sufficient to reverse social avoidance behavior after chronic social defeat. **P < 0.05, **P < 0.01, ***P < 0.001 by two-way ANOVA (c,f,h) and students t-test (d,e,g,i).
To manipulate Rac1, we utilized herpes-simplex virus (HSV)-mediated gene transfer of bicistronic constructs containing green fluorescent protein (GFP) and either a dominant negative Rac1 (RacDN), a constitutively active Rac1 (RacCA), or Cre recombinase infused directly into the NAc (Fig. 4a,b). Viral over-expression of HSV-CRE in the NAc of floxed Rac1 (fl/fl Rac1) mice to locally knockout the Rac1 gene (Supplemental Fig. 8a) strongly induces susceptibility to social avoidance (Fig. 4c–d; Supplemental Fig. 9a–b) and anhedonia, measured by reduced sucrose preference (Fig. 4e), following a microdefeat. Similarly, HSV-mediated overexpression of RacDN recapitulates this pro-susceptibility phenotype (Fig. 4f–g; Supplemental Fig. 9c–d). Conversely, HSV-mediated overexpression of RacCA to restore Rac1 levels following chronic social defeat, rescues the susceptible phenotype, reverting previously susceptible mice to control and resilient levels of social avoidance behavior (Fig. 4h–I; Supplemental Fig. 9e–f). These data indicated that direct reversal of stress-induced downregulation of Rac1 has strong anti-stress efficacy.
Rac1 controls stress-induced formation of immature spine structures
Chronic social defeat stress induces the formation of highly plastic and immature stubby dendritic spines on MSNs in the NAc. These dendritic alterations are associated with a smaller post synaptic density and a greatly increased frequency of excitatory drive that seems to be necessary and sufficient for the expression of depression-related phenotypes in mice[17]. In order to understand the mechanism leading to the induction of immature stubby dendritic spines on NAc MSNs, we first examined cofilin, a critical downstream Rac1 target important for actin severing and shown previously to regulate immature spine structure[31]. NAc MSN dendritic segments were examined 48 hrs following chronic social defeat stress through a combinatorial approach utilizing automated 3D dendritic spine reconstruction from HSV-GFP infected neurons overlaid with cofilin immunohistochemistry (Fig. 5a–b; Supplemental Fig. 10a). Chronic social defeat stress resulted in a selective increase in total cofilin puncta colocalization with immature stubby spines, but not thin, mushroom, or total spine density (Fig. 5c). Within the tissue set used for immunohistochemical analysis, we also observed a replication of previous data where chronic social defeat stress resulted in an induction in total stubby spine density on MSN dendrites (Supplemental Fig. 9b).
Figure 5
Chronic social defeat regulates immature stubby spine formation through a Rac1 dependent mechanism. (a–b) Representative 63x confocal z-stack images of MSN dendritic segments from control and susceptible mice following chronic social defeat. White arrows in the GFP panel indicate dendritic stubby spines. White circles in merge panel highlight colocalization of GFP stubby spines and cofilin puncta, while yellow circles indicate non-co-localized stubby spines. Measurement bar is 10 μm. (c) Chronic social defeat stress results in increased cofilin puncta in stubby dendritic spines, but not in thin, mushroom, or by total spine density. *P < 0.05 by students t-test, 48 neurons, 4–5 mice per group. (d) Representative 3D reconstructions of HSV-infected MSN dendritic segments. White arrows delineate stubby spines, yellow arrows delineate mushroom spines, and blue arrows delineate thins spines. (e,i) Over expression of RacCA is sufficient to reverse chronic social defeat stress induction of stubby spines, and is significantly correlated with social avoidance behavior. (f–h,j) Neither chronic social defeat nor RacCA modulates thin, mushroom or total dendritic spine density. *P < 0.05 by two-way ANOVA, 61 neurons, 3–5 mice per group (e–h), P <0.05 compared by Pearson's r (i,j); measurement bar is 5 μm.
Having observed Rac1 dependent control over depression-associated behavior, we next wanted to determine if a rescue of the downregulated Rac1 with HSV-RacCA following chronic stress is sufficient to prune away these stubby spines (Fig. 5d). We injected HSV vectors following 10 days of chronic social defeat stress and found that overexpression of RacCA reversed the induction of stubby spines previously seen in susceptible mice (Fig. 5e), and there was a strong trend for reduced thin spines (Fig. 5f), suggesting that RacCA may selectively target immature spine structures. Importantly, stubby spine number correlated with social avoidance behavior (Fig. 5i–j). We observed no effect of social defeat or Rac1 overexpression on mushroom spines (Fig. 5g) or total dendritic spine (Fig. 5h) density. To determine whether Rac1 is sufficient for immature dendritic spine formation on medium spiny neurons in the NAc, we performed an identical dendritic spine morphology analysis in conditional fl/fl Rac1mice following a subthreshold microdefeat stress (Fig. 6a). Removal of Rac1 causes a large induction of both thin and stubby spine density in control and microdefeated mice (Fig. 6b–e), while having no effect on mushroom spine density (Fig. 6d). Interestingly, an additive effect is observed on stubby spines where acute social defeat almost doubles the spine density of fl/fl Rac1mice (Fig. 6b), and this induction in both stubby and thin spines is correlated with social interaction ratio (Fig. 6f–g). While future studies will need to examine these morphological changes in human post mortem tissue from depressed subjects, new methodologies and techniques will need to be developed for this purpose.
Figure 6
Conditional deletion of Rac1 gene in NAc medium spiny neurons in fl/fl Rac1 mice leads to the induction of immature synaptic structures. (a) Representative 3D reconstructions of HSV-infected MSN dendritic segments. White arrows delineate stubby spines, yellow arrows delineate mushroom spines, and blue arrows delineate thins spines. (b) Stubby spine density is increased in mice after Rac1 gene deletion and further increased by microdefeat stress. (c) Rac1 deletion similarly increases thin dendritic spine density in control and microdefeated mice. (d) Neither microdefeat stress nor Rac1 deletion regulates mushroom spine density. (e) Rac1 deletion also increases total spine density. (f,g) Both stubby and thin spine density are strongly correlated with social avoidance behavior. *P < 0.05, ***P < 0.001 by two-way ANOVA, 60 neurons, 4 mice per group (b–e), P <0.05 compared by Pearson's r (f,g); measurement bar is 5 μm.
DISCUSSION
Our data shows a novel mechanism whereby chronic stress or depression regulates the transcriptional profile of Rac1 in the NAc of rodents and humans through an epigenetic mechanism. Intriguingly, Rac1 transcriptional tone is normalized by chronic imipramine treatment in mice following chronic social defeat and is positively correlated with treatment response, suggesting that this adaptation may be necessary for effective antidepressant treatment. However, in the majority of MDD subjects found to be on antidepressant at the time of suicide, normal Rac1 expression and altered chromatin modifications along the Rac1 promoter and upstream regions were not restored, suggesting a need for more direct Rac1 targeting strategies to achieve therapeutic effects in this patient population. Functionally, in mice, selective genetic deletion of Rac1 and viral mediated gene-transfer of Rac1 mutants, or epigenetic modulation through class 1 HDAC inhibition, reveals that accumbal Rac1 signaling is both sufficient and necessary for social avoidance and anhedonia behavioral responses and synaptic structural plasticity. Together, these data suggest that small RhoGTPase signaling pathways, and Rac1 specifically, are viable candidates for future development as antidepressant therapeutic agents when targeted to the nucleus accumbens.Indeed, small RhoGTPases have been heavily implicated in the neuropathogenesis of several psychiatric disorders including fragile X mental retardation[32], Rett syndrome[33] and schizophrenia[34]. Under non-pathological conditions, Rac1 plays an important role in neuronal development[35], axon guidance[36] and learning and memory processes[37]. In regard to dendritic spines, as a general rule, increased synaptogenesis and functional synaptic plasticity is tightly correlated with the size and shape of a dendritic spine; as spines shift along a continuum from immature (stubby and thin) to mature (mushroom) they also shift towards greater synaptic strength and stability[38,39]. Within neuronal populations, there is wealth of evidence supporting a role for Rac1 in dendritic spine morphogenesis and maintenance[34,40-42] via modulation of cofilin spatiotemporal dynamics[43,44].This signaling cascade is therefore exceptionally positioned to regulate the delicate interface between extra-cellular stimuli and dynamic reorganization of the actin cytoskeleton to accommodate neuronal transduction. The transcriptional downregulation of this system consequently plays an important role in setting the threshold for subsequent experience-dependant plasticity within NAc. Our data suggest that stress-induced decreases in Rac1 expression result in concurrent increases in immature stubby spine formation and cofilin localization within these spines. Recent findings have confirmed that decreased p21-activated kinase 3 (PAK3) activity, an immediate downstream effecter of Rac1, leads to both an increase in the growth of new, immature spines and an impairment of plasticity-mediated spine stabilization that interferes with the formation of persistent stable spines[45]. A feature of chronic stress exposure is a shift towards synaptic instability[17,46]. Such synaptic instability is relieved through the application of low-doses of ketamine[14,46], which has rapid antidepressant efficacy. Ketamine treatments normalize stress-induced immature spine formation resulting in a greater proportion of mature dendritic spines in pyramidal neurons of the prefrontal cortex[46]. This “plasticity consolidation” treatment strategy[11] may be occurring through a RhoGTPase-dependent mechanism, however, the specifics of this need to be teased apart in future studies.It is noteworthy that within the NAc both cold water forced swim[47] and chronic social defeat stress[17,48] result in enhanced glutamatergic synaptic plasticity. In the case of social defeat, this coincides with the formation of immature stubby spines with smaller post-synaptic densities (PSDs) and a higher frequency of mini excitory postsynaptic currents (mEPSCs). The finding of increased excitatory drive in NAc is somewhat surprising since previous work shows that deep brain stimulation (DBS) in the NAc of treatment-resistant depression subjects produces a profound antidepressant response[49,50]. However, DBS stimulates both excitatory and inhibitory neuronal populations, as well as fibers of passage that transit through the generalized region of stimulation. Further, the stimulation parameters used in such treatments are extremely super-physiological in frequency and amplitude that, based on Channel Rhodopsin studies, may result in de-sensitization of excitatory responses[51]. How this ultimately regulates the diverse cell populations within the NAc is still unknown.While there are clearly many acute biochemical events acting directly in the synapse that may mediate NAc plasticity, data here points to a more sustained long-lasting mechanism through downregulation of Rac1, as a result of stressful experience, to cause social avoidance and anhedonia. Thus, epigenetic mechanisms of sustained transcriptional disruptions provide a logical basis for such long-lasting synaptic restructuring events. While more general strategies of epigenetic regulation, through administration of histone deactelyase inhibitors[20] or histone demethylases[52], may show significant antidepressant efficacy by enhancing Rac1 expression, still further refinement is necessary. A recent advance in targeting gene specific chromatin states using zinc finger artificial transcription factors that bind specific consensus sequences[53] allow for targeted epigenetic therapeutics to act on specific genes to reverse long-term chromatin disruptions, for example, on Rac1. However, until these tools are more widely available for testing in humans, a more feasible therapeutic strategy may be to screen compounds that target either Rac1 activity, or more generally, excitatory synapse consolidation.In summary, we provide strong evidence that chronic stress induces long-term transcriptional downregulation of Rac1 through an epigenetic mechanism, robustly regulating NAc MSN synaptic structural and behavioral plasticity. Reversal of this endophenotype may present a novel therapeutic venue for exploration, and guide future therapeutics to target adaptive intracellular plasticity mechanisms.
Authors: Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava Journal: Am J Psychiatry Date: 2006-01 Impact factor: 18.112
Authors: Vincent Vialou; Alfred J Robison; Quincey C Laplant; Herbert E Covington; David M Dietz; Yoshinori N Ohnishi; Ezekiell Mouzon; Augustus J Rush; Emily L Watts; Deanna L Wallace; Sergio D Iñiguez; Yoko H Ohnishi; Michel A Steiner; Brandon L Warren; Vaishnav Krishnan; Carlos A Bolaños; Rachael L Neve; Subroto Ghose; Olivier Berton; Carol A Tamminga; Eric J Nestler Journal: Nat Neurosci Date: 2010-05-16 Impact factor: 24.884
Authors: Odelia Y N Bongmba; Luis A Martinez; Mary E Elhardt; Karlis Butler; Maria V Tejada-Simon Journal: Brain Res Date: 2011-05-17 Impact factor: 3.252
Authors: Anita E Autry; Megumi Adachi; Elena Nosyreva; Elisa S Na; Maarten F Los; Peng-fei Cheng; Ege T Kavalali; Lisa M Monteggia Journal: Nature Date: 2011-06-15 Impact factor: 49.962
Authors: Ti-Fei Yuan; Ang Li; Xin Sun; Huan Ouyang; Carlos Campos; Nuno B F Rocha; Oscar Arias-Carrión; Sergio Machado; Gonglin Hou; Kwok Fai So Journal: Mol Neurobiol Date: 2015-11-16 Impact factor: 5.590
Authors: Fikri Birey; Michelle Kloc; Manideep Chavali; Israa Hussein; Michael Wilson; Daniel J Christoffel; Tony Chen; Michael A Frohman; John K Robinson; Scott J Russo; Arianna Maffei; Adan Aguirre Journal: Neuron Date: 2015-11-20 Impact factor: 17.173
Authors: Joseph G Duman; Shalaka Mulherkar; Yen-Kuei Tu; Jinxuan X Cheng; Kimberley F Tolias Journal: Neurosci Lett Date: 2015-05-21 Impact factor: 3.046
Authors: Yossef Goffer; Duo Xu; Sarah E Eberle; James D'amour; Michelle Lee; David Tukey; Robert C Froemke; Edward B Ziff; Jing Wang Journal: J Neurosci Date: 2013-11-27 Impact factor: 6.167
Authors: Daniel B McKim; Jenna M Patterson; Eric S Wohleb; Brant L Jarrett; Brenda F Reader; Jonathan P Godbout; John F Sheridan Journal: Biol Psychiatry Date: 2015-07-26 Impact factor: 13.382